We hypothesize that DFNA5 may be a valuable epigenetic biomarker, based upon large differences in DFNA5 methylation between breast cancer and healthy breast tissues, strong indications for its role as tumor suppressor gene, and its function in regulated cell death. The gene discussed is GSDME; the disease is breast carcinoma.